Multizonal observational study conducted by clinical practitioners on Repatha® use in patients with hyperlipidemia (ZERBINI): Colombian results Heidy M. Roncancio; Julián R. Lugo-Peña; Ángel A. García; Janeth Leal; Carlos A. Hoyos; Johnny A. Beltrán; César L. Cruz; Carol Paez-Cano; Mariana Pineda-Posada; Eduardo Contreras;

Analysis of the evolocumab (Repatha®) patient support program for patients with cardiovascular disease in Colombia Ángel Alberto García-Peña; Mariana Pineda-Posada; Carol Páez-Canro; César Cruz; Daniel Samacá-Samacá;

Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors Jose Seijas-Amigo; Mónica Gayoso-Rey; María José Mauriz-Montero; Pedro Suarez-Artime; Antonia Casas-Martinez; María Dominguez-Guerra; Lara Gonzalez-Freire; Ana Estany-Gestal; Alberto Codero-Fort; Moisés Rodriguez-Mañero; Jose Ramón Gonzalez-Juanatey;